2017 a record year for LEO Pharma with sales hitting over 10 billion kroner

In 2017, LEO Pharma helped more than 80 million patients, increased revenues by 8% in local currencies, and generated revenues at more than 10 billion Danish kroner ($1.65 billion) for the first time in the company’s 110 year old history.

Earnings before interest and tax (EBIT) more than doubled to 852 million kroner despite significant investments in new products, on sales of 10.48 billion kroner.

The foundation-owned company’s operating profit before depreciation and amortization was above expectations going up 49% from 1,346 million kroner in 2016 to 2,005 million kroner in 2017.